11 results match your criteria: "Marseille Public Hospital System (APHM)[Affiliation]"
Obstet Gynecol
January 2010
From the Department of Obstetrics and Gynecology, Marseille Public Hospital System (APHM); Unité des rickettsies, IFR 48, CNRS-IRD UMR 6236, Faculté de Médecine, Université de la Méditerranée; and Centre d'investigation clinique 9502, Marseille, France.
Objective: To estimate the relationship between vaginal quantification of the main microorganisms related with bacterial vaginosis and the risk of preterm delivery among women with preterm labor.
Methods: Molecular methods were used to prospectively quantify Lactobacillus species, Gardnerella vaginalis, Atopobium vaginae, and Mycoplasma hominis in vaginal fluid samples from women admitted for spontaneous preterm labor with intact membranes from July 2007 through July 2008. The primary outcome measure was the relationship between bacterial concentration at admission and preterm delivery, before 37 weeks of gestation.
Contraception
July 2009
Department of Obstetrics and Gynecology, Marseille Public Hospital System (APHM), 13385 Marseille, France.
Background: The purpose of our study was to determine whether cervical preparation with laminaria tents would improve the procedure of second- and third-trimester medical termination of pregnancy (TOP) in terms of duration of abortion and hospitalization.
Study: A retrospective comparative study of two historical periods of women undergoing second- and third-trimester medical TOP at a single tertiary care center from September 2004 to December 2006 was conducted. During Period A, patients received oral mifepristone and vaginal misoprostol, while during Period B, laminaria tents were added.
Ultrasound Obstet Gynecol
May 2007
Department of Obstetrics and Gynecology, Marseille Public Hospital System (APHM), Marseille, France.
Objective: To develop a nomogram to predict macrosomia with a combination of clinical and ultrasound variables.
Methods: Data from 194 women who underwent sonographic fetal weight estimation were used to develop and calibrate a nomogram to predict fetal macrosomia. The nomogram was subjected to 200 bootstrap resamples for internal validation and to reduce overfit bias.
Acta Obstet Gynecol Scand
April 2006
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), France.
Objective: To identify risk factors for forceps delivery during first pregnancy.
Materials And Methods: A retrospective case-control study was carried out in a tertiary maternity ward between January 2001 and December 2003. A total of 582 nulliparous women, with full-term (>37 weeks gestation), singleton, cephalic pregnancies, who delivered by the vaginal route with or without instrumental assistance were evaluated.
Eur J Obstet Gynecol Reprod Biol
November 2006
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), Marseille, France.
Aust N Z J Obstet Gynaecol
October 2005
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), Marseille, France.
Objective: To analyse maternal and neonatal morbidity associated with instrumental delivery using Thierry's spatulas.
Methods: Between January 2001 and December 2003, 570 nulliparous women with term, singleton, cephalic pregnancies gave birth by either instrumental (n = 279) or spontaneous vaginal delivery (n = 291) and were studied in a retrospective case-control study. Maternal and neonatal morbidity were compared in the instrumental vs.
Eur J Obstet Gynecol Reprod Biol
July 2005
Department of Oncologic Gynecology, Marseille Public Hospital System (APHM), Hôpital de la Conception, Service de Gynécologie A, Marseille, France.
Objective: The purpose of this study was to evaluate a conservative cold-knife section technique for treatment of cervical intraepithelial neoplasia (CIN). This procedure can be adapted to patient age, preservation of childbearing potential and extent of dysplasia.
Design: Prospective study.
Dis Colon Rectum
July 2005
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), Marseille, France.
Purpose: This study was designed to evaluate persistent anal symptoms after first instrumental delivery beyond the postpartum period.
Methods: This prospective study was performed in a cohort of primiparas who underwent instrumental delivery from January 1, 2001 to September 30, 2002. Questionnaires for anal symptoms were completed in the maternity ward on the day after delivery and by mail or telephone up to 12 months after the end of the inclusion period.
Eur J Obstet Gynecol Reprod Biol
May 1999
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), France.
Objective: Conservative treatment for ductal carcinoma in situ of the breast exposes patients to the risk of infiltrating recurrence which can lead to metastasis. The primary purposes of this retrospective study were to evaluate diagnostic and therapeutic methods over a 10-year period and to validate prognostic factors. This information should greatly improve patient selection for conservative treatment or mastectomy.
View Article and Find Full Text PDFInt J Cancer
June 1998
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), France.
Hormone-replacement therapy (HRT) is widely used by post-menopausal women. Although this treatment may slightly increase the incidence of breast cancer, more and more cases are diagnosed while women are taking HRT. The purpose of this study was to ascertain the influence of HRT on prognostic factors and outcome of breast cancer.
View Article and Find Full Text PDFInt J Cancer
September 1997
Department of Gynecology and Obstetrics, Marseille Public Hospital System (APHM), France.
The relationship between pregnancy and the outcome of breast cancer remains controversial. The purpose of this study was to determine the prognostic value of pregnancy at the time of diagnosis of primary infiltrating breast cancer. In a retrospective multi-center study we compared a group of 154 patients presenting pregnancy-associated (PA) breast cancer with a control group of 308 patients presenting non-pregnancy-associated (non-PA) breast cancer.
View Article and Find Full Text PDF